Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Perri

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
Cancers|June 2, 2021
Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled TrialFrancesco Perri, Francesco Longo, Roberta Fusco, et al.
Cancers|October 24, 2020
Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal CancerAlessandro Ottaiano, Michele Caraglia, Annabella Di Mauro, et al.
Experimental and Therapeutic Medicine|October 11, 2021
Patients affected by squamous cell carcinoma of the head and neck: A population particularly prone to developing severe forms of COVID-19Francesco Perri, Anna Crispo, Franco Ionna, et al.
Biology|March 26, 2022
Radiomics Metrics Combined with Clinical Data in the Surgical Management of Early-Stage (cT1-T2 N0) Tongue Squamous Cell Carcinomas: A Preliminary StudyUmberto Committeri, Roberta Fusco, Elio Di Bernardo, et al.
The American Journal of Gastroenterology|December 18, 2008
High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized studyAngelo Andriulli, Silvano Loperfido, Rosaria Focareta, et al.
Frontiers in Pharmacology|April 5, 2018
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I TrialCarlo Buonerba, Pietro De Placido, Dario Bruzzese, et al.
Scientific Reports|March 11, 2022
A proposal for the reference intervals of the Italian microbiota "scaffold" in healthy adultsDavide Sisti, Valerio Pazienza, Fabio Piccini, et al.
Frontiers in Microbiology|February 23, 2026
Human papillomavirus 16 E6 oncoprotein promotes up-regulation of RNA-binding protein Sam68 in head and neck cancerAndrea Cerasuolo, Tiziana Pecchillo Cimmino, Salvatore Gagliarde, et al.
Cancers|November 13, 2025
Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell CancerMorena Fasano, Francesco Perri, Mario Pirozzi, et al.
Plos One|November 24, 2016
Oral Ondansetron versus Domperidone for Acute Gastroenteritis in Pediatric Emergency Departments: Multicenter Double Blind Randomized Controlled TrialFederico Marchetti, Maurizio Bonati, Alessandra Maestro, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
Cancers|June 2, 2021
Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled TrialFrancesco Perri, Francesco Longo, Roberta Fusco, et al.
Cancers|October 24, 2020
Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal CancerAlessandro Ottaiano, Michele Caraglia, Annabella Di Mauro, et al.
Experimental and Therapeutic Medicine|October 11, 2021
Patients affected by squamous cell carcinoma of the head and neck: A population particularly prone to developing severe forms of COVID-19Francesco Perri, Anna Crispo, Franco Ionna, et al.
Biology|March 26, 2022
Radiomics Metrics Combined with Clinical Data in the Surgical Management of Early-Stage (cT1-T2 N0) Tongue Squamous Cell Carcinomas: A Preliminary StudyUmberto Committeri, Roberta Fusco, Elio Di Bernardo, et al.
The American Journal of Gastroenterology|December 18, 2008
High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized studyAngelo Andriulli, Silvano Loperfido, Rosaria Focareta, et al.
Frontiers in Pharmacology|April 5, 2018
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I TrialCarlo Buonerba, Pietro De Placido, Dario Bruzzese, et al.
Scientific Reports|March 11, 2022
A proposal for the reference intervals of the Italian microbiota "scaffold" in healthy adultsDavide Sisti, Valerio Pazienza, Fabio Piccini, et al.
Frontiers in Microbiology|February 23, 2026
Human papillomavirus 16 E6 oncoprotein promotes up-regulation of RNA-binding protein Sam68 in head and neck cancerAndrea Cerasuolo, Tiziana Pecchillo Cimmino, Salvatore Gagliarde, et al.
Cancers|November 13, 2025
Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell CancerMorena Fasano, Francesco Perri, Mario Pirozzi, et al.
Plos One|November 24, 2016
Oral Ondansetron versus Domperidone for Acute Gastroenteritis in Pediatric Emergency Departments: Multicenter Double Blind Randomized Controlled TrialFederico Marchetti, Maurizio Bonati, Alessandra Maestro, et al.
Pageof 23